Biotech news
Americas
A US presidential hopeful for the Democratic Party has urged the US to support a request that would permanently free poor countries from their responsibility to grant patent protection for drugs. 30 September 2015
Americas
Concern surrounding how the Unified Patent Court will operate echoes the worry that US patent owners had ahead of the Patent Trial and Appeal Board’s implementation, a US law firm has observed. 28 September 2015
Americas
Researchers should keep in mind that broad claims applying the discovery of a biomarker and disease correlation are currently patentable in Europe but not in the US. Andrew Carridge and Neil Thornton of Reddie & Grose report. 17 September 2015
Biotech
Supplementary protection certificates should take effect once an applicant for marketing authorisation has been notified of the authorisation, an advocate-general has urged the Court of Justice of the European Union to confirm. 10 September 2015
Biotech
An adviser at Europe’s highest court is expected to issue an opinion on whether the term of a supplementary protection certificate begins once it is authorised or when the applicant has been notified about it. 9 September 2015
Americas
A group of 23 law professors has urged the US Court of Appeals for the Federal Circuit to re-hear the Ariosa v Sequenom dispute en banc. 2 September 2015
Americas
Hedge fund manager Kyle Bass’s group the Coalition for Affordable Drugs has targeted two patents owned by the University of Pennsylvania in the latest petition for an inter partes review. 1 September 2015
Americas
The US Food and Drug Administration has proposed using four-letter suffixes to name biosimilar drugs. 1 September 2015
Pharma
The competence in various areas of the new Unified Patent Court is a matter of conjecture, as Paul England and Christof Höhne of law firm Taylor Wessing report. 27 August 2015
Americas
Law firm Dechert has hired Andrea Reid as partner to the firm’s intellectual property practice in Boston. 14 August 2015